Cannara Biotech Inc. (TSX:LOVE)
Canada flag Canada · Delayed Price · Currency is CAD
1.770
-0.010 (-0.56%)
Apr 28, 2026, 3:55 PM EST

Cannara Biotech Ratios and Metrics

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Apr '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21 2020 - 2018
Market Capitalization
1751656190118149
Upgrade
Market Cap Growth
59.36%168.86%-32.29%-23.64%-20.54%112.60%
Upgrade
Enterprise Value
187198105131146160
Upgrade
Last Close Price
1.771.800.681.001.351.70
Upgrade
PE Ratio
16.2812.599.5113.0251.35-
Upgrade
PS Ratio
1.551.540.751.583.308.75
Upgrade
PB Ratio
1.451.610.701.131.772.32
Upgrade
P/TBV Ratio
1.451.610.701.131.772.32
Upgrade
P/FCF Ratio
10.8512.0519.05---
Upgrade
P/OCF Ratio
6.338.225.7315.29--
Upgrade
EV/Sales Ratio
1.661.841.282.294.079.40
Upgrade
EV/EBITDA Ratio
7.737.047.627.9216.9158.11
Upgrade
EV/EBIT Ratio
10.509.1313.6911.1730.253041.19
Upgrade
EV/FCF Ratio
11.6214.4732.55---
Upgrade
Debt / Equity Ratio
0.280.410.550.570.730.33
Upgrade
Debt / EBITDA Ratio
1.411.473.452.755.547.15
Upgrade
Debt / FCF Ratio
2.123.0515.04---
Upgrade
Net Debt / Equity Ratio
0.100.270.470.520.540.20
Upgrade
Net Debt / EBITDA Ratio
0.520.973.042.514.214.63
Upgrade
Net Debt / FCF Ratio
0.771.9912.98-10.46-1.68-0.38
Upgrade
Asset Turnover
0.660.660.550.430.330.23
Upgrade
Inventory Turnover
1.311.321.411.141.401.39
Upgrade
Quick Ratio
1.150.830.730.701.751.63
Upgrade
Current Ratio
3.062.402.502.443.462.82
Upgrade
Return on Equity (ROE)
9.48%13.75%7.68%9.48%3.52%-2.98%
Upgrade
Return on Assets (ROA)
6.49%8.37%3.23%5.48%2.77%0.04%
Upgrade
Return on Invested Capital (ROIC)
9.10%12.08%6.09%10.45%5.36%0.09%
Upgrade
Return on Capital Employed (ROCE)
11.70%16.10%6.00%9.70%4.20%0.10%
Upgrade
Earnings Yield
5.81%7.95%10.52%7.68%1.95%-1.03%
Upgrade
FCF Yield
9.22%8.30%5.25%-4.39%-18.20%-22.26%
Upgrade
Buyback Yield / Dilution
-3.00%-1.08%-1.83%-2.16%-14.80%-7.26%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.